This TMX Group Limited (X.to) stock analysis is the final post in my series of analyses of Financial Data & Stock Exchanges industry participants. Please click here to access previous posts. NOTE: All dollar values related to X are in $CAD. I view the Financial Data & Stock Exchanges industry as an attractive industry in [...]
Microsoft's dividend safety will appeal to investors who rely on dividend income and who have a low tolerance for risk. I encourage you to read my recently published Microsoft - (MSFT) 'AAA' Dividend Safety guest post at Dividend Power if your investor profile includes a low-risk tolerance. I wish you much success on your journey [...]
At the time of my November 11, 2020 post, Intact Financial Corporation (IFC) had just announced its intent to acquire RSA Insurance Group PLC with Tryg A/S. In that post, I disclose the purchase of additional IFC shares. I also wrote a guest post at Value of Stocks on February 14, 2021. After these posts, [...]
In my August 10, 2021 Viatris (VTRS) stock analysis I reviewed Q2 and YTD financial results and the company's valuation based on guidance. I now revisit VTRS following the November 8, 2021 release of Q3 and YTD 2021 results and revised FY2021 guidance. Viatris - Stock Analysis - Business Overview VTRS's FY2020 Form 10-K provides [...]
In my September 3, 2021 post I disclose the purchase of additional Mastercard Incorporated (MA) shares @ $340.3929/share in one of the 'Core' accounts in the FFJ Portfolio. On October 26, Visa (V) released Q4 and FY2021 results. The share price of both V and MA plunged so I acquired more shares in both companies [...]
In my February 8, 2021 Merck & Co., Inc. (MRK) stock analysis I disclosed that my findings led me to initiate a 300 share position in one of the 'Core' accounts in the FFJ Portfolio. I subsequently analyzed Q1 2021 results and FY2021 guidance in my May 3, 2021 MRK stock analysis and disclosed the [...]
Previous Exxon Mobil (XOM) posts are accessible in the FFJ Archives. In my previous XOM stock analysis, I concluded shares were attractively valued and acquired another 200 shares in a 'Core' account in the FFJ Portfolio. At the time of that post, XOM's share price was ~$57. The share price is now ~$64.50 and with [...]
Previous Chevron Corporation (CVX) posts are accessible in the FFJ Archives. In my most recent post, I concluded CVX shares were attractively valued and acquired additional shares in a 'Core' account in the FFJ Portfolio. At the time of that post, CVX's share price was ~$99. The share price is now ~$114.50 and with the [...]
This Cboe Global Markets, Inc. (CBOE) stock analysis is the 9th in my series of analyses of Financial Data & Stock Exchanges industry participants. Previous posts within this series are accessible here. I view the Financial Data & Stock Exchanges industry as an attractive industry in which to invest for the long term. I currently [...]
In anticipation of strong Q3 and YTD2021 results, I initiated a 200 shares Abbvie Inc. (ABBV) position @ $108.70/share on October 22, 2021 in one of the 'Core' accounts in the FFJ Portfolio. With the release of Q3 and YTD2021 results on October 29, I now provide this ABBV stock analysis. ABBV - Stock Analysis [...]